A ‘devastating’ pregnancy complication and a new trial drug that gives one mum hope

A New Hope for Ectopic Pregnancies

A mother from Cardiff, Helen Corsi-Cadmore, shares her heartbreaking experience of losing two fallopian tubes to ectopic pregnancies. Ectopic pregnancies occur when the embryo implants and grows outside the uterus, often in a fallopian tube, posing a significant risk of internal bleeding. Emergency surgery is usually required to remove the affected tube, leading to devastating consequences for women facing this complication.

A new £1.6 million trial is set to investigate the effectiveness of a trial drug called mifepristone in treating ectopic pregnancies. Helen, who had twins through IVF after her harrowing experiences, believes this trial could be a game-changer for women facing similar challenges. She works as a project co-ordinator at the Ectopic Pregnancy Trust, which is contributing to this groundbreaking research led by the University of Aberdeen.

Key Points:

  • 1 in 80 pregnancies is ectopic, putting many women at risk.
  • Mifepristone will be tested to see if it is more effective than current treatments.
  • The drug trial aims to help women avoid emergency surgery.

Helen candidly shares, “The first ectopic pregnancy I had ended up with a ruptured fallopian tube, leading to its removal. This was an extremely challenging time for me, both physically and emotionally. The second ectopic pregnancy resulted in the loss of my remaining tube, which was mentally more distressing due to concurrent life changes.”

The trial, funded by Medical Research Council and National Institute for Health and Care Research, will be conducted across 40 early pregnancy units in the UK. The lead researcher, Dr. Andrea Woolner, emphasizes the need for advancements in ectopic pregnancy management to reduce the emotional and physical toll on women and their families.

Support and Progress:

  • Mifepristone aims to reduce the need for emergency surgery.
  • The trial offers hope for women facing ectopic pregnancies.
  • Results are expected in 2027, promising a potential breakthrough in treatment.

With the trial’s initiation later this year, experts from esteemed universities globally, along with the Ectopic Pregnancy Trust, will collaborate to drive innovation in managing this devastating complication. Though saving an ectopic pregnancy is not currently possible, this trial aims to revolutionize the treatment landscape, offering hope to women like Helen and countless others navigating similar challenges.